Mitochondrial-associated PCD signature defines immune landscape, therapeutic sensitivity, and prognosis in hepatocellular carcinoma
{{output}}
Mitochondrial-associated programmed cell death signatures (MPCDS) have emerged as critical indicators of cancer progression and treatment response. In hepatocellular carcinoma (HCC), mitochondrial dysfunction and dysregulated PCD pathways are prevalent, yet th... ...
